3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Colorectal Neoplasms
62
Carcinoma, Hepatocellular
25
Neoplasm Metastasis
15
Rectal Neoplasms
11
Colonic Neoplasms
10
Gastrointestinal Stromal Tumors
9
Sarcoma
6
Ovarian Neoplasms
5
Osteosarcoma
5
Glioblastoma
5
Cholangiocarcinoma
5
Stomach Neoplasms
4
Melanoma
4
Liver Neoplasms
4
Sarcoma, Ewing
3
Pancreatic Neoplasms
3
Neoplasms
3
Leukemia, Myeloid, Acute
3
Esophageal Neoplasms
3
Colorectal Cancer Metastatic
3
Carcinoma, Non-Small-Cell Lung
3
Thyroid Neoplasms
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Hematologic Neoplasms
2
Hemangiosarcoma
2
Gastrointestinal Neoplasms
2
Interventions
Filgrastim
4
Proton Therapy
3
Docetaxel
3
regorafenib
2
Sunitinib
2
Ifosfamide
2
Gemcitabine
2
Carboplatin
2
temsirolimus
1
pegfilgrastim
1
liposomal doxorubicin
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
ivosidenib
1
itacitinib
1
etoposide phosphate
1
capivasertib
1
baricitinib
1
apatinib
1
angiotensin I (1-7)
1
abemaciclib
1
Zoledronic Acid
1
Weight-Bearing
1
Trabectedin
1
Topotecan
1
Thiotepa
1
Thalidomide
1
Taxes
1
TQ-B3525
1
Surveys and Questionnaires
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Chondrosarcoma
×
regorafenib
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled
NCT02389244
2025-09-16
REGOBONE
UNICANCER
Phase 2
Active not recruiting
163 enrolled